The claim
The Food and Drug Administration’s decision to revoke its emergency use authorization of hydroxychloroquine and chloroquine for COVID-19 “removes a potential barrier” and makes it easier to access the drugs.
Sources and attribution
Original review: FactCheck.org. Structured data compiled by Data Commons under CC BY 4.0. Publisher article content is subject to its own terms.
Updated